(Q36614192)

15 August 2017

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival (English)

1 reference

15 August 2017

1 reference

C Parker

1

1 reference

15 August 2017

D Muston

2

1 reference

15 August 2017

J Melia

3

1 reference

15 August 2017

S Moss

4

1 reference

15 August 2017

D Dearnaley

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

94

1 reference

15 August 2017

10

1 reference

15 August 2017

1361-1368

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603105

15 August 2017

0 references

cites work

Radical prostatectomy versus watchful waiting in early prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361275

20-year outcomes following conservative management of clinically localized prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361275

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361275

Prostate Cancer Grade Assignment: The Effect of Chronological, Interpretive and Translation Bias

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361275

National practice patterns and time trends in androgen ablation for localized prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361275

Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361275

A universal pattern of mortality decline in the G7 countries

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361275

Second round results of the Finnish population-based prostate cancer screening trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361275

Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361275

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361275

Population-based study of long-term survival in patients with clinically localised prostate cancer.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361275

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study

20 September 2018

2 references

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603105

21 January 2018

12 December 2020

Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis

1 reference

12 December 2020

Pathologic Features of Prostate Cancer Found at Population-Based Screening With a Four-Year Interval

1 reference

12 December 2020

Competing risks as a multi-state model

1 reference

12 December 2020

Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age

1 reference

12 December 2020

Survival prospects after screen-detection of prostate cancer

1 reference

12 December 2020

Sex or survival: trade-offs between quality and quantity of life

1 reference

12 December 2020

Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study

1 reference

12 December 2020

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6603105

1 reference

15 August 2017

1 reference

15 August 2017

1 reference